Cargando…

The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation

OBJECTIVES: We investigated the influence of spinal cord stimulation (SCS) on IFN-γ, IL-1β, IL-6, TNF-α, IL-10, and TGF-β serum levels in failed back surgery syndrome (FBSS) patients. The study will try to give new insights into the mechanism of SCS action and the role of IFN-γ and other cytokines i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamieniak, Piotr, Bielewicz, Joanna, Grochowski, Cezary, Litak, Jakub, Bojarska-Junak, Agnieszka, Daniluk, Beata, Trojanowski, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348905/
https://www.ncbi.nlm.nih.gov/pubmed/30755780
http://dx.doi.org/10.1155/2019/2606808
_version_ 1783390187695374336
author Kamieniak, Piotr
Bielewicz, Joanna
Grochowski, Cezary
Litak, Jakub
Bojarska-Junak, Agnieszka
Daniluk, Beata
Trojanowski, Tomasz
author_facet Kamieniak, Piotr
Bielewicz, Joanna
Grochowski, Cezary
Litak, Jakub
Bojarska-Junak, Agnieszka
Daniluk, Beata
Trojanowski, Tomasz
author_sort Kamieniak, Piotr
collection PubMed
description OBJECTIVES: We investigated the influence of spinal cord stimulation (SCS) on IFN-γ, IL-1β, IL-6, TNF-α, IL-10, and TGF-β serum levels in failed back surgery syndrome (FBSS) patients. The study will try to give new insights into the mechanism of SCS action and the role of IFN-γ and other cytokines in neuropathic pain (NP) development. MATERIALS AND METHODS: Clinical and biochemical assessment was conducted in four groups of patients: group 0 consisted of 24 FBSS patients qualified to SCS therapy, group 1 included 17 patients who were one month after implantation, group 2 featured 12 patients who were 3 months after the implantation, and group C (the control group) with no NP. Clinical status was assessed with the use of Numeric Rating Scale (NRS), the Pain Rating Index of McGill Pain Questionnaire (SF-MPQ), the Oswestry Disability Index (ODI), and Beck Depression Inventory (BDI). The plasma concentrations of IFN-γ were ascertained by an immunoenzymatic method. RESULTS: We found a significant difference between the patients before SCS and controls' serum level of IFN-γ. Similarly, a significantly higher level of TNF-α and significantly lower level of IL-10 in FBSS patients than controls were observed. The significant differences were not observed between SCS patients 3 months after the procedure and controls' serum level of IFN-γ and other cytokines. We noticed a positive correlation between IFN-γ concentration with NRS back value before SCS and positive correlation between IFN-γ concentration after SCS with NRS leg value before SCS. Higher IFN-γ concentrations accompanied higher NRS values. Levels of TGF-β and IL-10 may correlate with physical ability and depressive behavior. CONCLUSIONS: SCS did not influence serum cytokine levels significantly. Serum concentration of IFN-γ may be recognized as an occasional pain factor because of its significantly higher level in FBSS patients versus controls and higher IFN-γ value accompanying higher pain intensity.
format Online
Article
Text
id pubmed-6348905
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-63489052019-02-12 The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation Kamieniak, Piotr Bielewicz, Joanna Grochowski, Cezary Litak, Jakub Bojarska-Junak, Agnieszka Daniluk, Beata Trojanowski, Tomasz Dis Markers Research Article OBJECTIVES: We investigated the influence of spinal cord stimulation (SCS) on IFN-γ, IL-1β, IL-6, TNF-α, IL-10, and TGF-β serum levels in failed back surgery syndrome (FBSS) patients. The study will try to give new insights into the mechanism of SCS action and the role of IFN-γ and other cytokines in neuropathic pain (NP) development. MATERIALS AND METHODS: Clinical and biochemical assessment was conducted in four groups of patients: group 0 consisted of 24 FBSS patients qualified to SCS therapy, group 1 included 17 patients who were one month after implantation, group 2 featured 12 patients who were 3 months after the implantation, and group C (the control group) with no NP. Clinical status was assessed with the use of Numeric Rating Scale (NRS), the Pain Rating Index of McGill Pain Questionnaire (SF-MPQ), the Oswestry Disability Index (ODI), and Beck Depression Inventory (BDI). The plasma concentrations of IFN-γ were ascertained by an immunoenzymatic method. RESULTS: We found a significant difference between the patients before SCS and controls' serum level of IFN-γ. Similarly, a significantly higher level of TNF-α and significantly lower level of IL-10 in FBSS patients than controls were observed. The significant differences were not observed between SCS patients 3 months after the procedure and controls' serum level of IFN-γ and other cytokines. We noticed a positive correlation between IFN-γ concentration with NRS back value before SCS and positive correlation between IFN-γ concentration after SCS with NRS leg value before SCS. Higher IFN-γ concentrations accompanied higher NRS values. Levels of TGF-β and IL-10 may correlate with physical ability and depressive behavior. CONCLUSIONS: SCS did not influence serum cytokine levels significantly. Serum concentration of IFN-γ may be recognized as an occasional pain factor because of its significantly higher level in FBSS patients versus controls and higher IFN-γ value accompanying higher pain intensity. Hindawi 2019-01-14 /pmc/articles/PMC6348905/ /pubmed/30755780 http://dx.doi.org/10.1155/2019/2606808 Text en Copyright © 2019 Piotr Kamieniak et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kamieniak, Piotr
Bielewicz, Joanna
Grochowski, Cezary
Litak, Jakub
Bojarska-Junak, Agnieszka
Daniluk, Beata
Trojanowski, Tomasz
The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation
title The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation
title_full The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation
title_fullStr The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation
title_full_unstemmed The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation
title_short The Elevated Serum Level of IFN-γ in Patients with Failed Back Surgery Syndrome Remains Unchanged after Spinal Cord Stimulation
title_sort elevated serum level of ifn-γ in patients with failed back surgery syndrome remains unchanged after spinal cord stimulation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348905/
https://www.ncbi.nlm.nih.gov/pubmed/30755780
http://dx.doi.org/10.1155/2019/2606808
work_keys_str_mv AT kamieniakpiotr theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT bielewiczjoanna theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT grochowskicezary theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT litakjakub theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT bojarskajunakagnieszka theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT danilukbeata theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT trojanowskitomasz theelevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT kamieniakpiotr elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT bielewiczjoanna elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT grochowskicezary elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT litakjakub elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT bojarskajunakagnieszka elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT danilukbeata elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation
AT trojanowskitomasz elevatedserumlevelofifnginpatientswithfailedbacksurgerysyndromeremainsunchangedafterspinalcordstimulation